Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    "Oncogenic osteomalacia"
Show Display Options
Rank Status Study
1 Unknown  68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia
Conditions: Oncogenic Osteomalacia;   Mesenchymal Tumor
Intervention: Drug: 68Ga-DOTATATE
2 Recruiting Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia
Condition: Tumor Induced Oncogenic Osteomalacia
3 Active, not recruiting Study of KRN23 in Adult Subjects With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Conditions: Tumor Induced Osteomalacia (TIO);   Epidermal Nevus Syndrome (ENS)
Intervention: Drug: KRN23
4 Active, not recruiting A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Condition: Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Intervention: Drug: KRN23
5 Completed Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia
Conditions: Osteomalacia;   Neoplasms
6 Recruiting Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
Condition: Hypophosphatemia
7 Terminated Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
Condition: Osteomalacia
Intervention: Drug: Osteomalacia

Indicates status has not been verified in more than two years